Critical role for Atm in suppressing V(D)J recombination-driven thymic lymphoma

Genes and Development

Volumn 13, Issue 10, 1999, Pages 1246-1250

  Liao, Mai Jing ^a   Van Dyke, Terry ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Atm; Lymphoma; Tumor suppression; V(D)J recombination

Indexed keywords

PROTEIN P53; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANTIGEN RECOGNITION; APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOGENICITY; CHROMOSOME TRANSLOCATION; DNA DAMAGE; GENE ACTIVITY; GENE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; THYMUS LYMPHOMA; TRANSGENE; TUMOR SUPPRESSOR GENE;

ANIMALIA; ATAXIA; ATAXIA TELANGIECTASIA;

EID: 0033563099     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.13.10.1246     Document Type: Article

References (36)

1. Agrawal, A., Q.M. Eastman, and D.G. Schatz. 1998. Transposition mediated by RAG1 and RAG2 and its implications for the evolution of the immune system. Nature 394: 744-751.
2. Banin, S., L. Moyal, S. Shieh, Y. Taya, C.W. Anderson, L. Chessa, N.I. Smorodinsky, C. Prives, Y. Reiss, Y. Shiloh, and Y. Ziv. 1998. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281: 1674-1677.
3. Barlow, C., S. Hirotsune, R. Paylor, M. Liyanage, M. Eckhaus, F. Collins, Y. Shiloh, J.N. Crawley, T. Ried, D. Tagle, and A. Wynshaw-Boris. 1996. Atm-deficient mice: A paradigm of Ataxia Telangiectasia. Cell 86: 159-171.
4. Barlow, C., K. Brown, C. Deng, D. Tagle, and A. Wynshaw-Boris. 1997. Atm selectively regulates distince p53-dependent cell-cycle checkpoint and apoptotic pathways. Nat. Genet. 17: 453-456.
5. Canman, C.E., D.S. Lim, K.A. Cimprich, Y. Taya, K. Tamai, K. Sakaguchi, E. Appella, M.B. Kastan, and J.D. Siliciano. 1998. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281: 1677-1679.
6. Danska, J.S. and C.J. Guidos. 1997. Essential and perilous: V(D)J recombination and DNA damage checkpoints in lymphocyte precursors. Semin. Immunol. 9: 199-206.
7. Elledge, S.J. 1996. Cell cycle checkpoints: Preventing an identity crisis. Science 274: 1664-1672.
8. Elson, A., Y. Wang, C. Daugherty, C. Morton, F. Zhou, J. Campos-Torres, and P. Leder. 1996. Pleiotropic defects in ataxia-telangiectasia protein-deficient mice. Proc. Natl. Acad. Sci. 93: 13084-13089.
9. Herzog, K.H., M.J. Chong, M. Kapsetaki, J.I. Morgan, and P.J. McKinnon. 1998. Requirement for Atm in ionizing radiation-induced cell death in the developing central nervous system. Science 280: 1089-1091.
10. Hiom, K., M. Melek, and M. Gellert. 1998. DNA transposition by the RAG1 and RAG2 proteins: A possible source of oncogenic translocations. Cell 94: 463-470.
11. Jeggo, P.A., A.M. Carr, and A.R. Lehmann. 1998. Splitting the ATM: Distinct repair and checkpoint defects in ataxia-telangiectasia. Trends Genet. 14: 312-316.
12. Kastan, M.B., Q. Zhan, W.S. El-Deiry, F. Carrier, T. Jacks, W. V. Walsh, B.S. Plunkett, B. Vogelstein, and A.J. Fornace, Jr. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in Ataxia-Telangiectasia. Cell 71: 587-597.
13. Kirsch, I.R. 1994. V(D)J recombination and ataxia-telangiectasia: A review. Int. J. Radiat. Biol. 66: S97-S108.
14. Kirsch, I.R. and F. Lista. 1997. Lymphocyte-specific genomic instability and risk of lymphoid malignancy. Semin. Immunol. 9: 207-215.
15. Kobayashi, Y., B. Tycko, A.L. Soreng, and J. Sklar. 1991. Transrearrangements between antigen receptor genes in normal human lymphoid tissues and in ataxia telangiectasia J. Immunol. 147: 3201-3209.
16. Lavin, M.F. and Y. Shiloh. 1997. The genetic defect in ataxia-telangiectasia. Annu. Rev. Immunol. 15: 177-202.
17. Lewis, S.M. 1994. The mechanism of V(D)J joining: Lessons from molecular, immunological, and comparative analyses. Adv. Immunol. 56: 27-150.
18. Liao, M.-J., X. Zhang, R. Hill, J. Gao, M. Qumsiyeh, W. Nichols, and T. Van Dyke. 1998. No requirement for V(D)J recombination in p53-deficient thymic lymphoma. Mol. Cell. Biol. 18: 3495-3501.
19. Lipkowitz, S., M.H. Stern, and I.R. Kirsch. 1990. Hybrid T cell receptor genes formed by interlocus recombination in normal and ataxia-telangiectasis lymphocytes J. Exp. Med. 172: 409-418.
20. McBlane, J.F., D.C. van Gent, D.A. Ramsden, C. Romeo, C.A. Cuomo, M. Gellert, and M.A. Oettinger. 1995. Cleavage at a V(D)J recombination signal requires only RAG1 and RAG2 proteins and occurs in two steps. Cell 83: 387-395.
21. Meyn, M.S. 1995. Ataxia-telangiectasia and cellular responses to DNA damage. Cancer Res. 55: 5991-6001.
22. Mombaerts, P., J. Iacomini, R.S. Johnson, K. Herrup, S. Tonegawa, and V. Papaioannou. 1992. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68: 869-877.
23. Nacht, M. and T. Jacks. 1998. V(D)J recombination is not required for the development of lymphoma in p53-deficient mice. Cell Growth Differ. 9: 131-138.
24. Nowell, P.C. 1997. Genetic alterations in leukemias and lymphomas: Impressive progress and continuing complexity. Cancer Genet. Cytogenet. 94: 13-19.
25. Pandita, T.K. and W.N. Hittelman. 1992. Initial chromosome damage but not DNA damage is greater in ataxia telangiectasia cells. Radiat. Res. 130: 94-103.
26. Paulovich, A.G., D.P. Toczyski, and L.H. Hartwell. 1997. When checkpoints fail. Cell 88: 315-321.
27. Pircher, H., K. Burki, R. Lang, H. Hengartner, and R.M. Zinkernagel. 1989. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 342: 559-561.
28. Plug, A., A. Peters, Y. Xu, K. Keegan, M. Hoekstra, D. Baltimore, P. de Boer, and T. Ashley. 1997. ATM and RPA in meiotic chromosome synapsis and recombination. Nat. Genet. 17: 457-461.
29. Rabbitts, T.H. 1994. Chromosomal translocations in human cancer. Nature 372: 143-149.
30. Shiloh, Y. and G. Rotman. 1996. Ataxia-telangiectasia and the ATM gene: linking neurodegeneration, immunodeficiency, and cancer to cell cycle checkpoints J. Clin. Immunol. 16: 154-260.
31. Shinkai, Y., G. Rathbun, K. Lam, E. Oltz, V. Stewart, M. Mendelsohn, J. Charron, M. Datta, F. Young, A. Stall, and F. Alt. 1992. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68: 855-867.
32. Shinkai, Y., S. Koyasu, K. Nakayama, K. Murphy, D. Loh, E. Reinherz, and F. Alt. 1993. Restoration of T cell development in RAG-1-deficient mice by functional TCR transgenes. Science 259: 822-825.
33. Taylor, A.M.R., J.A. Metcalfe, J. Thick, and Y.-F. Mak. 1996. Leukemia and lymphoma in ataxia telangiectasia. Blood 87: 423-438.
34. Westphal, C., S. Rowan, C. Schmaltz, A. Elson, D. Fisher, and P. Leder. 1997. atm and p53 cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity. Nat. Genet. 16: 397-401.
35. Xu, Y. and D. Baltimore. 1996. Dual roles of ATM in the cellular response to radiation and in cell growth control. Genes & Dev. 10: 2401-2410.
36. Xu, Y., T. Ashley, E.E. Brainerd, R.T. Bronson, M.S. Meyn, and D. Baltimore. 1996. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes & Dev. 10: 2411-2422.